Clazakizumab
Product Specifications
CAS Number
1236278-28-6
Target
Interleukin, SARS-CoV
Related Pathways
Immunology/Inflammation, Microbiology/Virology
Bioactivity
Clazakizumab, a monoclonal antibody, demonstrates high affinity and specificity towards the interleukin-6 (IL-6) cytokine, potentially inhibiting the cytokine response in COVID-19 caused by SARS-CoV-2. It is also under research for treating psoriatic arthritis (PsA) and renal antibody-mediated rejection [1] [2].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1106823-01 0.02 mg (E-Coli)
Recombinant Gerbera hybrida 2-pyrone synthase (2PS)
Sign In for Pricing
View Details MBS1106823-02 0.02 mg (Yeast)
Recombinant Gerbera hybrida 2-pyrone synthase (2PS)
Sign In for Pricing
View Details MBS1106823-03 0.1 mg (E-Coli)
Recombinant Gerbera hybrida 2-pyrone synthase (2PS)
Sign In for Pricing
View Details MBS1106823-04 0.1 mg (Yeast)
Recombinant Gerbera hybrida 2-pyrone synthase (2PS)
Sign In for Pricing
View Details MBS1106823-05 0.02 mg (Baculovirus)
Recombinant Gerbera hybrida 2-pyrone synthase (2PS)
Sign In for Pricing
View Details